BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
PDX1
,
Fatty acid metabolic process
,
Hepatitis
,
Leukocyte
,
Nosology
,
Lovastatin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
antibody
Summary
General Info
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
Influence of anti-CD25 mAb on the transcriptome of activated PBMC
PBMCs of myelopathy/tropical spastic paraparesis patients treated with Fas agonist/antagonist mAbs
CD4+ T cells stimulated and then restimulated in the presence or absence of natalizumab
Chronic lymphocytic leukemia (CLL) tumors: progressors and non-progressors
Explore Curated Studies Results
Literature
Most Relevant Literature
A pivotal decade for bispecific antibodies?
Stability of anti-drug antibodies in human serum samples.
Immunoconjugates and bispecific antibodies: Trends in therapeutic success and commercial focus.
Developability considerations for bispecific and multispecific antibodies.
Engineered polyspecific antibodies: A new frontier in the field of immunotherapeutics.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
HPA Antibodies and the Distribution of Antigen and Antibodies
Polysaccharide Antibody Response Study
anti_endometrial Antibodies in Endometriosis
Antibodies and Liver Retransplantation
Characterization of Anti-FGFR3 Antibodies
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ